BURCELIN; Remy

Patent Applications and Registrations

Patent applications and USPTO patent grants for BURCELIN; Remy.The latest application filed is for "methods of enhancing the potency of incretin-based drugs in subjects in need thereof".

Company Profile

5.6.29

BURCELIN; Remy - Toulouse Cedex FR
Burcelin; Remy - Toulouse FR
BURCELIN; Remy - Auzeville-Tolosane FR
Burcelin; Remy - Escalquens FR
BURCELIN; Remy - Toulouse cedex 4 FR
Burcelin; Remy - Kantvik FI
Burcelin; Remy - Ramonville-St Agne FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Enhancing The Potency Of Incretin-based Drugs In Subjects In Need Thereof App 20220218768 - BURCELIN; Remy ; et al.	2022-07-14
Methods of enhancing the potency of incretin-based drugs in subjects in need thereof Grant 11,285,180 - Burcelin , et al. March 29, 2	2022-03-29
Use Of Mam Polypeptides For The Treatment Of Obesity And Obesity-related Disorders App 20210393737 - HEYMES; Christophe ; et al.	2021-12-23
Bifidobacteria For Treating Diabetes And Related Conditions App 20210322491 - Burcelin; Remy ; et al.	2021-10-21
Polydextrose For The Prevention And/or Treatment Of Heart Failure App 20210154217 - HEYMES; Christophe ; et al.	2021-05-27
Polydextrose For The Treatment Of Inflammatory Diseases App 20210100831 - HEYMES; Christophe ; et al.	2021-04-08
Vaccination Against Diabetes, Obesity And Complications Thereof App 20210069313 - BLASCO-BAQUE; Vincent ; et al.	2021-03-11
Vaccination against diabetes, obesity and complications thereof Grant 10,925,951 - Blasco-Baque , et al. February 23, 2	2021-02-23
Bifidobacteria For Treating Diabetes And Related Conditions App 20200316144 - Burcelin; Remy ; et al.	2020-10-08
Bifidobacteria For Treating Cardiac Conditions App 20200306322 - Burcelin; Remy ; et al.	2020-10-01
Lactic acid bacteria and bifidobacteria for treating endotoxemia Grant 10,543,239 - Burcelin , et al. Ja	2020-01-28
Methods Of Enhancing The Potency Of Incretin-based Drugs In Subjects In Need Thereof App 20190388486 - BURCELIN; Remy ; et al.	2019-12-26
Bifidobacteria For Treating Diabetes And Related Conditions App 20190307815 - BURCELIN; REMY ; et al.	2019-10-10
Vaccination Against Diabetes, Obesity And Complications Thereof App 20180369353 - BLASCO-BAQUE; Vincent ; et al.	2018-12-27
Polydextrose For The Prevention And/or Treatment Of Heart Failure App 20180360867 - HEYMES; Christophe ; et al.	2018-12-20
Bifidobacteria For Treating Cardiac Conditions App 20180207209 - BURCELIN; REMY ; et al.	2018-07-26
Bifidobacteria For Treating Diabetes And Related Conditions App 20180021391 - BURCELIN; REMY ; et al.	2018-01-25
Lactic Acid Bacteria And Bifidobacteria For Treating Endotoxemia App 20160113976 - BURCELIN; REMY ; et al.	2016-04-28
Lactic acid bacteria and bifidobacteria for treating endotoxemia Grant 9,259,447 - Burcelin , et al. February 16, 2	2016-02-16
Bifidobacteria For Treating Cardiac Conditions App 20150320808 - BURCELIN; Remy ; et al.	2015-11-12
Bifidobacteria For Treating Diabetes And Related Conditions App 20140348796 - Burcelin; Remy ; et al.	2014-11-27
Method For Predicting Insulinopenic Type 2 Diabetes App 20140186829 - Burcelin; Remy ; et al.	2014-07-03
Use Of Blood Or Tissue Bacteriome For Prediction, Diagnosis And Prevention Of Metabolic Diseases And Their Cardiovascular Complications App 20140086954 - Burcelin; Remy ; et al.	2014-03-27
Method For Predicting Abdominal Obesity App 20140088203 - Amar; Jacques ; et al.	2014-03-27
Special Composition For The Use Thereof As A Drug App 20130029996 - Burcelin; Remy ; et al.	2013-01-31
Lactic acid bacteria and bifidobacteria for treating endotoxemia App 20120183516 - Burcelin; Remy ; et al.	2012-07-19
Bifidobacteria for treating diabetes and related conditions App 20120107291 - Burcelin; Remy ; et al.	2012-05-03
Bacterial DNA as Markers of Cardiovascular and/or Metabolic Disease App 20120021421 - Amar; Jacques ; et al.	2012-01-26
New Uses of Lactic Acid Bacteria and Bifidobacteria App 20110189149 - Burcelin; Remy ; et al.	2011-08-04
Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes Grant 7,618,951 - Monsan , et al. November 17, 2	2009-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.